Independent
Tenure on this board
4.8 yrs
2 nominees · 2 ballot items.
1) Election of two Class II directors (Peter Feinberg and Laurie B. Keating); 2) Ratification of appointment of RSM US LLP as independent registered public accounting firm for fiscal 2026.
Elect two Class II directors (Peter Feinberg and Laurie B. Keating) to serve three-year terms expiring in 2029.
Ratify the appointment of RSM US LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
This management proposal requests that stockholders ratify the audit committee’s appointment of RSM US LLP as Immuneering’s independent registered public accounting firm for fiscal year 2026. Management and the audit committee present this as a routine corporate governance matter — they emphasize that RSM has served since 2020 and that the committee evaluated the firm’s qualifications, technical expertise, audit team, independence, global capabilities, and experience with the company; they note the firm has no disqualifying financial interests. The Board states that ratification is not required but seeks stockholder input as good governance and reserves the right to change auditors if it deems appropriate. For analysts, relevant context includes the disclosed audit and related fees (audit fees of $276,938 and audit-related fees of $168,525 for 2025), the audit committee’s role and independence, and the potential signal if stockholders were to reject ratification (triggering audit committee review). The Board recommends a vote FOR based on oversight of audit quality, cost-benefit considerations, and continuity of financial reporting and controls.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | FMR LLC | 8.82% | 5,707,949 | $30M |
| 2 | FMR LLC | 6.02% | 3,897,279 | $21M |
| 3 | Sanofi | 4.19% | 2,708,559 | $14M |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 3.54% | 2,288,341 | $12M |
| 5 | PRICE T ROWE ASSOCIATES INC /MD/ | 2.83% | 1,829,188 | $10M |
| 6 | MARSHALL WACE, LLP | 2.66% | 1,719,773 | $9M |
| 7 | MILLENNIUM MANAGEMENT LLC | 1.70% | 1,102,712 | $6M |
| 8 | BlackRock, Inc. | 1.42% | 920,981 | $5M |
| 9 | Occam Crest Management LP | 0.84% | 545,098 | $3M |
| 10 | BlackRock, Inc. | 0.81% | 523,086 | $3M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.